Akshar Dash, MD
Dr. Dash completed his medical school training at Texas Tech School of Medicine in 2020 and his Internal Medicine Residency at UTHealth Houston in 2023. He also completed his undergraduate education in biochemistry at UT Austin. As his experience involves…
Diego Reymunde Duran, MD
Ruda Mohaweche, MD
Puja B. Gandhi, MD, MPH
Dr. Puja Gandhi earned her BS in Human Biology and Anthropology from Emory University in Atlanta, Georgia. She earned her MPH from UTHealth Houston School of Public Health and her MD from McGovern Medical School at UTHealth Houston in 2018….
In Memoriam: Dr. Barbara Murray
Barbara E. Murray, MD, J. Ralph Meadows Professor of Medicine in the Division of Infectious Diseases, Department of Internal Medicine, died April 11, 2024. She was 76. A member of the Medical School’s ID faculty since 1980, she was a…
UTHealth Houston research: semaglutide reduces severity of fatty liver disease in people with HIV
Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston (external link). The use of semaglutide 1mg weekly was safe and effective in…
Jennifer M. Sunny, DO
UTHealth Houston report in NEJM: Deadly fungal infection acquired during surgery in Mexico led to death and brainstem, blood supply injuries
A life-threatening mold infection known as health care-associated Fusarium solani meningitis can be associated with a delayed, but devastating, injury to the brainstem and its blood supply among those infected, according to physicians from UTHealth Houston (external link). A report,…
UTHealth Houston opens recruitment in RISE-UP clinical drug trial for people with sickle cell anemia
A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth…
